Breast cancer

Updated 20 November 2017

Mammography costs soar for seniors, but detection rates stay the same

Research hasn't shown expensive technologies benefit women over 65-years-old.

The cost of breast cancer screening for older women has soared because of increased use of new technologies, but that hasn't led to earlier detection of breast cancer, a new study shows.

Researchers compared data from 2001-02 and 2008-09, and found that the use of screening mammography for Medicare-enrolled women without a history of breast cancer remained at about 42 percent.

Read: Breast cancer: myths and facts

There was a large increase in the use of digital mammography technology, which is more expensive than standard film technology ($115 versus $73 per mammogram). However, the newer technology has not been shown to be more effective in detecting breast cancer in women aged 65 and older, Yale School of Medicine researchers said.

They also discovered a significant increase in the use of other newer, more expensive technology for breast cancer screening and related procedures.

Overall, Medicare spending for breast cancer screening and related procedures rose from $666 million in 2001-02 to $962 million in 2008-09, according to a study in the July 1 issue of the Journal of the National Cancer Institute.

"Screening mammography is an important tool, but this rate of increase in cost is not sustainable," study co-author Dr. Brigid Killelea, an assistant professor of surgery, said in a Yale news release.

Read: Breast cancer: a single mom's journey to recovery

"We need to establish screening guidelines for older women that utilize technology appropriately, and minimize unnecessary biopsies and over-diagnosis to keep costs under control," she added.

Further studies are needed to identify which women will benefit from screening, and how to screen effectively and efficiently, study co-author Dr. Cary Gross said in the news release.

"But we cannot simply adopt new technologies because they theoretically are superior -- the health system cannot sustain it, and more importantly our patients deserve a sustained effort to determine which approaches to screening are effective and which ones are not," said Gross, director of the Yale Cancer Outcomes, Public Policy and Effectiveness Research Center.

"In some instances, breast cancer screening can save lives. But no woman wants to undergo testing if it is likely to cause more harm than good," Gross said.

Read more: 

Some breast cancers disappear
Antiperspirants and breast cancer
Boob jobs and breast cancer


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules